Skip to main content
Article
Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy
Journal of Clinical Oncology (2005)
  • Takuji Mori, University of California, Los Angeles
  • Steven J. O’Day, University of California, Los Angeles
  • Naoyuki Umetani, University of California, Los Angeles
  • Steve R. Martinez, University of California, Los Angeles
  • Minoru Kitago, University of California, Los Angeles
  • Kazuo Koyanagi, University of California, Los Angeles
  • Christine Kuo, University of California, Los Angeles
  • Teh-Ling Takeshima, University of California, Los Angeles
  • Robert Milford, University of California, Los Angeles
  • He-Jing Wang, University of California, Los Angeles
  • Vu D. Vu, University of California, Los Angeles
  • Sandy L. Nguyen, University of California, Los Angeles
  • Dave S.B. Hoon
Publication Date
December 20, 2005
DOI
10.1200/JCO.2005.02.9876
Citation Information
Takuji Mori, Steven J. O’Day, Naoyuki Umetani, Steve R. Martinez, et al.. "Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy" Journal of Clinical Oncology Vol. 23 Iss. 36 (2005) p. 9351 - 9358
Available at: http://works.bepress.com/dave-hoon/245/